These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 30134238)

  • 21. Cannabinoids in treatment-resistant epilepsy: A review.
    O'Connell BK; Gloss D; Devinsky O
    Epilepsy Behav; 2017 May; 70(Pt B):341-348. PubMed ID: 28188044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medicinal cannabis (Bedrolite) substitution therapy in inpatients with a psychotic disorder and a comorbid cannabis use disorder: A case series.
    Schipper R; Dekker M; de Haan L; van den Brink W
    J Psychopharmacol; 2018 Mar; 32(3):353-356. PubMed ID: 29039260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabinoids in the Treatment of Epilepsy.
    Friedman D; Devinsky O
    N Engl J Med; 2015 Sep; 373(11):1048-58. PubMed ID: 26352816
    [No Abstract]   [Full Text] [Related]  

  • 24. Medical Cannabis and the Treatment of Obstructive Sleep Apnea: An American Academy of Sleep Medicine Position Statement.
    Ramar K; Rosen IM; Kirsch DB; Chervin RD; Carden KA; Aurora RN; Kristo DA; Malhotra RK; Martin JL; Olson EJ; Rosen CL; Rowley JA;
    J Clin Sleep Med; 2018 Apr; 14(4):679-681. PubMed ID: 29609727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs.
    Parmar JR; Forrest BD; Freeman RA
    Res Social Adm Pharm; 2016; 12(4):638-54. PubMed ID: 26443472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Key elements of legal environments for medical use of cannabis in different countries.
    Knöss W; van de Velde M; Sandvos C; Cremer-Schaeffer P
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2019 Jul; 62(7):855-860. PubMed ID: 31165903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. THC and CBD: is medical cannabis overhyped or under-prescribed?
    Lyon L
    Brain; 2020 Apr; 143(4):e34. PubMed ID: 32227171
    [No Abstract]   [Full Text] [Related]  

  • 28. Simple and Fast Gas-chromatography Mass Spectrometry Assay to Assess Delta 9-Tetrahydrocannabinol and Cannabidiol in Dogs Treated with Medical Cannabis for Canine Epilepsy.
    Rotolo MC; Graziano S; Pellegrini M; Corlazzoli D; Antinori L; Porcarelli L; Pichini S
    Curr Pharm Biotechnol; 2017; 18(10):821-827. PubMed ID: 29173160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cannabis as a therapeutic agent: Focal topic].
    Radbruch L; Schäfer M
    Schmerz; 2016 Feb; 30(1):1-2. PubMed ID: 26809973
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cannabis for medical purposes and its prescription].
    Kiefer A; Eckert-Lill C; Bussick D; Hörnig M; Reimann H
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2019 Jul; 62(7):811-817. PubMed ID: 31187182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Path to the First FDA-Approved Cannabis-Derived Treatment and What Comes Next.
    Rubin R
    JAMA; 2018 Sep; 320(12):1227-1229. PubMed ID: 30193358
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy of Cannabis-Based Medicines for Pain Management: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Aviram J; Samuelly-Leichtag G
    Pain Physician; 2017 Sep; 20(6):E755-E796. PubMed ID: 28934780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. European Pain Federation (EFIC) position paper on appropriate use of cannabis-based medicines and medical cannabis for chronic pain management.
    Häuser W; Finn DP; Kalso E; Krcevski-Skvarc N; Kress HG; Morlion B; Perrot S; Schäfer M; Wells C; Brill S
    Eur J Pain; 2018 Oct; 22(9):1547-1564. PubMed ID: 30074291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of marijuana for medical purposes.
    Pinkas J; Jabłoński P; Kidawa M; Wierzba W
    Ann Agric Environ Med; 2016 Sep; 23(3):525-8. PubMed ID: 27660881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An Australian nationwide survey on medicinal cannabis use for epilepsy: History of antiepileptic drug treatment predicts medicinal cannabis use.
    Suraev AS; Todd L; Bowen MT; Allsop DJ; McGregor IS; Ireland C; Lintzeris N
    Epilepsy Behav; 2017 May; 70(Pt B):334-340. PubMed ID: 28238865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cannabis for medical purposes : Impact of the law of 6 March 2017 on physicians].
    Cremer-Schaeffer P; Knöss W; Broich K
    Schmerz; 2019 Oct; 33(5):378-383. PubMed ID: 31243538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is the clinical use of cannabis by oncology patients advisable?
    Bar-Sela G; Avisar A; Batash R; Schaffer M
    Curr Med Chem; 2014 Jun; 21(17):1923-30. PubMed ID: 24606496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Using cannabis in oncology: facts and myths].
    Küronya Z; Martin T; Kiss E; Szőnyi M; Bíró K
    Orv Hetil; 2020 Jun; 161(25):1035-1041. PubMed ID: 32516121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids.
    Pryce G; Riddall DR; Selwood DL; Giovannoni G; Baker D
    J Neuroimmune Pharmacol; 2015 Jun; 10(2):281-92. PubMed ID: 25537576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.